Skip navigation
Reports & Analysis Custom Research Research Subscriptions
Sign In / Create Account Cart
Sign In / Create Account Cart
  • Reports & Analysis
  • Custom Research
  • Research Subscriptions

Resources

  • Press Releases
  • Blog
  • Resources & Downloads
  • Impact Tracker

The Freedonia Group

  • Contact
  • About
  • Our Staff
  • Help Center
  • Career Opportunities
Back to Blog

Tariff Tracker: Will Proposed Chemical Tariffs Impact Pharma?

by Alecia Mouhanna

July 20, 2018

With tensions escalating and news developments seemingly every hour, the US has released a new list of $200 billion in Chinese goods subject to a proposed 10% tariff. That list includes a range of inorganic and organic chemicals of which China is a major supplier, including common products like chlorine, sulfur, carbon, nitrogen, oxygen, silicon, various acids, fluorides, chlorides, sulfates, nitrates, and more. The suggested tariffs would stand to impact countless US consumer and industrial markets, including, potentially, the pharmaceutical manufacturing industry, which often buys competitively priced basic chemicals from China to use in the production of drugs sold in the US.

In particular, this could pose a problem for generic drug manufacturers, who rely on cheap chemicals from China in order to mass produce medications and turn a profit. Higher import costs could turn into more expensive prescriptions at a time when soaring drug prices have already stretched US consumers thin.

However, the news isn’t all bad. The Trump administration appears to have tabled – for now – a much more harmful 25% tariff on China-sourced vaccines, insulin products and select raw ingredients for pharmaceuticals. This proposed tax was intended to undermine Chinese pharma manufacturers. But it likely would have caused much more significant problems for several major US patent-holders, including Johnson & Johnson, Merck & Co., and Pfizer, who might’ve faced international retaliation in the form of revoked patents and other penalties to their intellectual property holdings. 

Though it seems the US has backed off this threat for now, nothing is 100% safe in the current volatile trade environment - particularly considering that President Trump's most recent threat has been to tax all imports from China - so it’s certainly an industry to watch over the coming weeks and months.

To Learn More

Ready to learn more about tariffs? Check out the Freedonia Group's new white paper, in which our expert analysts outline the impact of tariffs on specific global markets.

About the Author

Alecia Mouhanna  is a Corporate Analyst at the Freedonia Group, where she researches and writes about a diverse range of topics, including construction and building materials, chemicals, packaging, and more.  

Have unique research needs?

Freedonia Custom Research listens intently to your needs and objectives. Then we work diligently to define and deliver a service to meet them.
Learn About Our Custom Research Services

Subscribe to Our Blog

Stay up to date with the latest information about new market research and news in areas relevant to your business from our analysts and team members.

Freedonia Group Blog Subscription

Provide the following details to subscribe.

  • Contact
  • About
  • Help Center
  • Career Opportunities
  • Press
  • User Agreement
  • Privacy Policy
  • Site Map
Facebook Linkedin Twitter

Additional Resources

  • Market Size Resources
  • Lawn Mowers Research
  • Global Lubricants Research
  • Global Paint & Coatings Research
  • Global Industrial Valves Research
  • Global Agricultural Equipment Research
  • Indoor Air Quality Equipment Research
  • Global Adhesives & Sealants Research
  • Hardscaping Products Research
  • Residential Landscaping Research
  • Food Packaging Research
  • Global Carpets & Rugs Research
  • Global Residential HVAC Research
Copyright © 2023 MarketResearch.com, Inc. All rights reserved.